MedPath

A Pilot Study of Topical Honey for the Treatment ofNappy Rash

Completed
Conditions
appy Rash
Nappy Rash
Skin - Dermatological conditions
Registration Number
ACTRN12612000563864
Lead Sponsor
Medical Research Institute of New Zealand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

Aged <5 at the time of enrolment
Doctors diagnosis of nappy rash

Exclusion Criteria

Requirement for topical or systemic corticosteroids, as judged by treating doctor
Requirement for antibiotic therapy, as judged by treating doctor
Known or suspected allergy to honey or dressings
Any other condition which, at the investigators discretion, it is believed may present a safety risk or impact the feasibility of the study or the study results

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
appy rash severity assessed by a 5 point nappy rash severity score.[At baseline and at final visit after 2 weeks]
Secondary Outcome Measures
NameTimeMethod
Subjective assessment of nappy rash severity, measured by visual analogue score (VAS)[At baseline and at final visit after 2 weeks];Objective assessment of global nappy rash severity, measured by VAS[At baseline and at final visit after 2 weeks];Acceptability of honey therapy, measured by VAS[At final visit after 2 weeks]
© Copyright 2025. All Rights Reserved by MedPath